Attached files
| file | filename |
|---|---|
| EX-4.3 - EX-4.3 - ARENA PHARMACEUTICALS INC | arna-ex43_819.htm |
| EX-31.1 - EX-31.1 - ARENA PHARMACEUTICALS INC | arna-ex311_15.htm |
| 10-K - 2019 10-K - ARENA PHARMACEUTICALS INC | arna-10k_20191231.htm |
| EX-32.1 - EX-32.1 - ARENA PHARMACEUTICALS INC | arna-ex321_14.htm |
| EX-31.2 - EX-31.2 - ARENA PHARMACEUTICALS INC | arna-ex312_12.htm |
| EX-23.1 - EX-23.1 - ARENA PHARMACEUTICALS INC | arna-ex231_7.htm |
Exhibit 21.1
Subsidiaries of Arena Pharmaceuticals, Inc.
As of December 31, 2019
125 Royalty Inc., a Delaware corporation
356 Royalty Inc., a Delaware corporation
Arena Pharmaceuticals Development GmbH, a limited liability company organized under the laws of Switzerland and having its domicile in Zug
Arena Pharmaceuticals GmbH in Liquidation, a limited liability company organized under the laws of Switzerland and having its domicile in Zofingen
Arena Pharmaceuticals Limited, a limited liability company organized under the laws of Ireland and having its domicile in Dublin
API Development LTD, a company incorporated in the Cayman Islands with limited liability